- Home
- FOLD vs MIR Comparison
FOLD vs MIR Comparison
Compare FOLD & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FOLD | MIR |
|---|---|---|
| Founded | 2002 | 2005 |
| Country | United States | United States |
| Employees | N/A | 3281 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.6B |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | FOLD | MIR |
|---|---|---|
| Price | $14.40 | $18.37 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 8 |
| Target Price | $27.25 | ★ $27.63 |
| AVG Volume (30 Days) | 3.0M | ★ 3.3M |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.50 | $24.05 |
| Revenue Next Year | $18.59 | $7.40 |
| P/E Ratio | ★ N/A | $195.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.66 | $12.00 |
| 52 Week High | $14.39 | $30.28 |
Technical Indicators
Market Signals| Indicator | FOLD | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 71.09 | 33.73 |
| Support Level | $14.21 | N/A |
| Resistance Level | N/A | $22.23 |
| Average True Range (ATR) | 0.02 | 1.04 |
| MACD | -0.02 | -0.13 |
| Stochastic Oscillator | 87.50 | 0.00 |
Price Performance
Historical ComparisonAbout FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.